Zhongwei Xu

Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis

W. Han, Liping Wang, Yi Zhang, 2015, Oncotarget.

Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia

Wen-qian Li, P. Lu, Xiangqun Li, 2021, Cancer Immunology, Immunotherapy.

Two major genes associated with autoimmune arthritis, Ncf1 and Fcgr2b, additively protect mice by strengthening T cell tolerance

R. Holmdahl, Huqiao Luo, V. Urbonaviciute, 2022, Cellular and Molecular Life Sciences.

Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis

W. Han, Liping Wang, Yi Zhang, 2015, Oncotarget.